ExodusPoint Capital Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$238K	Buy	+34,438	New	+$266K	﹤0.01%	1357
2025 Q4	–	Sell	-68,103	Closed	-$340K	–	2141
2025 Q3	$340K	Buy	68,103 +46,561	+216%	+$216K	﹤0.01%	1277
2025 Q2	$102K	Sell	21,542 -57,618	-73%	-$252K	﹤0.01%	1356
2025 Q1	$363K	Buy	79,160 +47,654	+151%	+$222K	﹤0.01%	1191
2024 Q4	$151K	Sell	31,506 -94,144	-75%	-$452K	﹤0.01%	1384
2024 Q3	$589K	Buy	+125,650	New	+$674K	0.01%	1134
2023 Q4	–	Sell	-150,399	Closed	-$650K	–	2106
2023 Q3	$650K	Buy	150,399 +76,577	+104%	+$425K	0.01%	1145
2023 Q2	$486K	Buy	+73,822	New	+$473K	0.01%	1370
2022 Q4	–	Sell	-10,099	Closed	-$100K	–	2178
2022 Q3	$100K	Sell	10,099 -128,077	-93%	-$1.35M	﹤0.01%	1745
2022 Q2	$1.51M	Buy	138,176 +65,045	+89%	+$674K	0.02%	912
2022 Q1	$827K	Buy	73,131 +28,316	+63%	+$372K	0.01%	1265
2021 Q4	$703K	Buy	+44,815	New	+$781K	0.01%	1245
2021 Q3	–	Sell	-17,034	Closed	-$366K	–	2684
2021 Q2	$366K	Sell	17,034 -37,368	-69%	-$669K	0.01%	1616
2021 Q1	$817K	Buy	54,402 +41,515	+322%	+$672K	0.02%	1040
2020 Q4	$169K	Buy	+12,887	New	+$155K	﹤0.01%	1767
2020 Q1	–	Sell	-26,968	Closed	-$443K	–	1680
2019 Q4	$443K	Buy	+26,968	New	+$408K	0.01%	931